Dayna McManus

910 total citations
40 papers, 312 citations indexed

About

Dayna McManus is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Dayna McManus has authored 40 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Clinical Biochemistry. Recurrent topics in Dayna McManus's work include Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (8 papers) and COVID-19 Clinical Research Studies (6 papers). Dayna McManus is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (8 papers) and COVID-19 Clinical Research Studies (6 papers). Dayna McManus collaborates with scholars based in United States. Dayna McManus's co-authors include Jeffrey Topal, Sunish Shah, Matthew W. Davis, Maricar Malinis, Brian Cicali, Audun Lier, Sheldon Campbell, David R. Peaper, Manisha Juthani‐Mehta and Rupak Datta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Dayna McManus

36 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dayna McManus United States 10 167 83 60 43 32 40 312
Ali Ardekani Iran 9 115 0.7× 62 0.7× 28 0.5× 39 0.9× 18 0.6× 29 379
J Ryan Bariola United States 10 308 1.8× 291 3.5× 36 0.6× 15 0.3× 46 1.4× 31 472
Élie Haddad Lebanon 8 111 0.7× 74 0.9× 42 0.7× 24 0.6× 5 0.2× 33 307
Hayden T. Schwenk United States 10 129 0.8× 173 2.1× 33 0.6× 29 0.7× 20 0.6× 46 344
Moustafa Abdelaal Hegazi Egypt 11 128 0.8× 70 0.8× 48 0.8× 34 0.8× 16 0.5× 23 299
Kkot Sil Lee South Korea 7 77 0.5× 59 0.7× 77 1.3× 23 0.5× 25 0.8× 20 258
Kylie Alcorn Australia 7 141 0.8× 63 0.8× 33 0.6× 17 0.4× 25 0.8× 12 349
Filippo Lagi Italy 13 287 1.7× 96 1.2× 60 1.0× 11 0.3× 5 0.2× 56 438
D. B. May United States 10 50 0.3× 69 0.8× 33 0.6× 21 0.5× 13 0.4× 13 298
Isabel Cristina Hurtado Colombia 6 194 1.2× 29 0.3× 33 0.6× 32 0.7× 4 0.1× 27 311

Countries citing papers authored by Dayna McManus

Since Specialization
Citations

This map shows the geographic impact of Dayna McManus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayna McManus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayna McManus more than expected).

Fields of papers citing papers by Dayna McManus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayna McManus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayna McManus. The network helps show where Dayna McManus may publish in the future.

Co-authorship network of co-authors of Dayna McManus

This figure shows the co-authorship network connecting the top 25 collaborators of Dayna McManus. A scholar is included among the top collaborators of Dayna McManus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayna McManus. Dayna McManus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Sunish, Kathleen K. Adams, Lloyd Clarke, et al.. (2024). Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections. International Journal of Antimicrobial Agents. 65(3). 107403–107403.
2.
McManus, Dayna, et al.. (2023). Dosing implications for liposomal amphotericin B in pregnancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(5). 452–462.
3.
Davis, Matthew W., et al.. (2023). Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO). BMC Infectious Diseases. 23(1). 258–258. 3 indexed citations
4.
McManus, Dayna, et al.. (2022). Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia. Clinics in Chest Medicine. 44(2). 299–319.
5.
Roberts, Scott C., Nathan D. Grubaugh, Tara Alpert, et al.. (2021). An outbreak of SARS‐CoV‐2 on a transplant unit in the early vaccination era. Transplant Infectious Disease. 24(2). e13782–e13782. 5 indexed citations
6.
7.
McManus, Dayna, et al.. (2021). Nocardia thailandica Brain Abscess in an Immunocompromised Patient. SHILAP Revista de lepidopterología. 2021. 1–4. 3 indexed citations
8.
9.
McManus, Dayna, et al.. (2020). Evaluation of the negative predictive value of methicillin-resistant Staphylococcus aureus nasal swab screening in patients with acute myeloid leukemia. Infection Control and Hospital Epidemiology. 42(7). 853–856. 9 indexed citations
10.
Davis, Matthew W., Dayna McManus, Alan Koff, et al.. (2020). Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients. Infection Control and Hospital Epidemiology. 41(11). 1335–1337. 10 indexed citations
11.
Goshua, George, Yiwen Liu, Matthew L. Meizlish, et al.. (2020). Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis. Blood. 136(Supplement 1). 23–24. 1 indexed citations
12.
Datta, Rupak, Jeffrey Topal, Dayna McManus, et al.. (2020). Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey. Palliative Medicine. 35(1). 236–241. 9 indexed citations
13.
Shah, Sunish, et al.. (2019). 2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A. Open Forum Infectious Diseases. 6(Supplement_2). S925–S925. 1 indexed citations
14.
McManus, Dayna, et al.. (2019). Improved mortality in Staphylococcus aureus bacteremia with the involvement of antimicrobial stewardship team and infectious disease consultation. Infection Control and Hospital Epidemiology. 40(8). 932–935. 11 indexed citations
15.
Datta, Rupak, Jeffrey Topal, Dayna McManus, et al.. (2019). Perspectives on antimicrobial use at the end of life among antibiotic stewardship programs: A survey of the Society for Healthcare Epidemiology of America Research Network. Infection Control and Hospital Epidemiology. 40(9). 1074–1076. 12 indexed citations
16.
McManus, Dayna, et al.. (2018). Utility of fosfomycin as antibacterial prophylaxis in patients with hematologic malignancies. Supportive Care in Cancer. 26(6). 1979–1983. 2 indexed citations
17.
Datta, Rupak, Dayna McManus, Jeffrey Topal, & Manisha Juthani‐Mehta. (2018). Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases. Open Forum Infectious Diseases. 5(1). ofx277–ofx277. 9 indexed citations
18.
Datta, Rupak, Dayna McManus, Jeffrey Topal, Vincent Quagliarello, & Manisha Juthani‐Mehta. (2018). 162. Association Between Antibiotic Use and Multidrug-Resistant Organism Detection in Advanced Cancer Patients on Palliative Chemotherapy. Open Forum Infectious Diseases. 5(suppl_1). S14–S15. 1 indexed citations
19.
McManus, Dayna, et al.. (2017). 934: UTILIZING THE CARBAPENEM-VALPROIC ACID DRUG INTERACTION IN THE MANAGEMENT OF VALPROIC ACID OVERDOSE. Critical Care Medicine. 46(1). 450–450. 5 indexed citations
20.
Anderson, Anthony D., et al.. (2017). Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient. Medical Mycology Case Reports. 17. 11–13. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Ardekani Breakdown of academic impact, for papers by J Ryan Bariola Breakdown of academic impact, for papers by Élie Haddad Breakdown of academic impact, for papers by Hayden T. Schwenk Breakdown of academic impact, for papers by Moustafa Abdelaal Hegazi Breakdown of academic impact, for papers by Kkot Sil Lee Breakdown of academic impact, for papers by Kylie Alcorn Breakdown of academic impact, for papers by Filippo Lagi Breakdown of academic impact, for papers by D. B. May Breakdown of academic impact, for papers by Isabel Cristina Hurtado
Rankless by CCL
2026